Quality

Jenny Craig Debuts Max Up, Its Most Complete And Effective Weight Loss Program Ever

Retrieved on: 
Tuesday, December 28, 2021
Muscle, Metabolism, Quality of life, FOMA, CEO, Nutritionist, U.S. News & World Report, Jenny Craig, Inc., Weight loss, Quality, Light, Program, Health, Education, Drinking water, Harvard Medical School, Review, Curriculum, McGovern Medical School, News, Faculty, Fasting, Burn, MD, Snack, Goal, FACP, Dietary supplement, Management

CARLSBAD, Calif., Dec. 28, 2021 /PRNewswire/ -- Jenny Craig , the leading weight loss and weight management company, today unveils its newest, most complete and effective program yet: Max Up .

Key Points: 
  • CARLSBAD, Calif., Dec. 28, 2021 /PRNewswire/ -- Jenny Craig , the leading weight loss and weight management company, today unveils its newest, most complete and effective program yet: Max Up .
  • Max Up is our very first complete program that's designed not only to maximize weight loss but also positively impact overall quality of life," said David Pastrana, CEO of Jenny Craig.
  • "Without Max Up, I would still be hiding on my couch in my house," said Angela T., Jenny Craig Max Up member.
  • The Jenny Craig program is designed to provide structure and support to help members lose weight and learn how to keep it off.

Reliable Top Mobile App Development Companies List in the United States by GoodFirms

Retrieved on: 
Friday, December 24, 2021
Ability, Omicron, IPhone, Delta, Blackberry, IPad, Quality, Mobile, Android, COVID-19, Technology, IPad Air 2, Software, List, NBT, Catalog, Research, The Next Big Thing (video game), Video game, Mobile phone, Motor vehicle, Microsoft Windows

Top Mobile App Development Companies in the USA and iPhone, Android, iPad, app developers Globally at GoodFirms:

Key Points: 
  • Top Mobile App Development Companies in the USA and iPhone, Android, iPad, app developers Globally at GoodFirms:
    Nowadays, people have become more prone to use smartphones, and most of them have switched to mobile apps to purchase essentials.
  • To make it easy for the service seekers to pick the most excellent mobile app developer as per their specific need of various platforms, GoodFirms.co has unlocked the list of top Mobile App Development Companies in the USA and the best app developers for different platforms like iPhone, Android,iPad, Windows, Blackberry, Wearable, Hybrid app development companies worldwide.
  • Take a Look at the List of Top Mobile App Development Companies in the USA and iPhone, Android,iPad, Windows, Blackberry, Wearable, Hybrid app developers Globally at GoodFirms:
    Top U.S. Based Mobile App Development Companies:
    Top iPhone App Development Companies:
    Top Android App Development Companies:
    Top iPad App Development Companies:
    KPIS PVT LTD, InApps Technology, BrancoSoft Private Limited, Fluper Ltd., Next Big Technology(NBT), Uplogic Technologies Pvt Ltd, Techugo, ToXSL Technologies Pvt.
  • GoodFirms is a Washington, D.C. based research firm that aligns its efforts in identifying the most prominent and efficient mobile app development companies that deliver results to their clients.

Natuzzi S.p.A. Announces Resignation of Its Chief Financial Officer

Retrieved on: 
Thursday, December 23, 2021
Manufacturing, Home Goods, Other Manufacturing, Luxury, Retail, Forest Stewardship Council, Workplace, ISO, NTZ, NYSE, Accounting, A, Quality, Safety, New, Company, ISO 9001, Employment, Social responsibility, Natuzzi, Environment

Natuzzi S.p.A. (NYSE: NTZ) (Natuzzi or the Company and, together with its subsidiaries, the Group) announced today the resignation of its Chief Financial Officer, Mr. Vittorio Notarpietro, to pursue other opportunities outside the Global Furniture Industry.

Key Points: 
  • Natuzzi S.p.A. (NYSE: NTZ) (Natuzzi or the Company and, together with its subsidiaries, the Group) announced today the resignation of its Chief Financial Officer, Mr. Vittorio Notarpietro, to pursue other opportunities outside the Global Furniture Industry.
  • The Company has already commenced an active search for a new Chief Financial Officer and is committed to find a profile that can continue to support the Groups retail and brand transformation currently ongoing.
  • The Company and Mr. Notarpietro have agreed that Mr. Notarpietro will continue to act as the Companys Chief Financial Officer until the effective date of his resignation in order to ensure an orderly transition.
  • Founded in 1959 by Pasquale Natuzzi, Natuzzi S.p.A. is one of the most renowned brands in the production and distribution of design and luxury furniture.

New Found Reviews 2021 Achievements

Retrieved on: 
Thursday, December 23, 2021
Mining, Minerals, Natural Resources, NYSE, Consultant, IPO, Forward-looking statement, COVID-19, Strike, Salvation Army camps in Canada, Appleton, Gold, TSX Venture Exchange, Nature, Program, JPB, Legislation, ICP, Geology, Risk, NYSE American, SEDAR, HQ, Workforce, Company, ALS, Multimedia, Gander International Airport, Figure 1, Accident, Person, National instrument, Kirkland Lake, NFG, VP, Queensway, Calendar, News, AFZ, Administrator, Review, Industry, Quality, Bias, Mineral, National Instrument 43-101, Highway, Road, Animal, Mining, Printed circuit board, Tunnel, Analysis, Lotto, John Keats, New Found Glory, Eastern Analytical Symposium

Raised over $120-million in 2021 in three financings at an average price of $9.34 per share, with the Company ending the year with $130-million in working capital.

Key Points: 
  • Raised over $120-million in 2021 in three financings at an average price of $9.34 per share, with the Company ending the year with $130-million in working capital.
  • Ended the year with a market capitalization of approximately $1.36 billion*, a 132% increase in calendar 2021.
  • Collin Kettell, Founder & Executive Chairman of New Found Gold stated: 2021 was a transformative year for New Found Gold.
  • Mr. Matheson consents to the publication of this news release dated December 23, 2021, by New Found.

Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department

Retrieved on: 
Tuesday, December 21, 2021
Psilocybin, Employment, Sindh Agriculture University, McMaster University, HACCP, SOP, Humidity, Pest control, FDR, Standard operating procedure, FRA, NextGen Healthcare, Environment, Board, Health, CSE, Safety, Research, Chemistry, Quality control, Management, Mushroom, University of London, Quality assurance, Psilocin, Quality, Fungus, Compliance, Certification, DNP, GAP, CAD, Company, Directive, Sale, Science, Knowledge, GMP, QA, Director, News, GLOBE, University, Unit production manager, Ventilation, Health Canada, ERP, Wye College, Medical device, Dietary supplement, Plant breeding, BC, Plant

Optimi believes that the completion of the physical inspection by Health Canada, subject to any comments or concerns, paves the way for Dealers License certification early in the new year.

Key Points: 
  • Optimi believes that the completion of the physical inspection by Health Canada, subject to any comments or concerns, paves the way for Dealers License certification early in the new year.
  • The department will oversee both quality control (QC) and quality assurance (QA) and compliance with Health Canadas QA guidelines pertaining to business, production, facility, security, storage, packaging, labeling as well as establishing and enforcing GAP, GMP, HACCP standards for the Mushroom program.
  • Im delighted to have the opportunity to introduce our new Quality Assurance department and cant wait to get started working with Raphael and Farkhanda.
  • Optimi is committed to expert cultivation and quality production subject to and in accordance with the terms of all applicable laws and governing regulations to ensure safe, superior Canadian fungi production.

DGAP-News: Mainz BioMed Appoints Karen Richards as Vice President, Regulatory Affairs to Lead US FDA Approval Process

Retrieved on: 
Tuesday, December 21, 2021
DGAP, Trial of the century, ISO 9001, COVID-19, CLIA, Biomarker, Private Securities Litigation Reform Act, Forward-looking statement, FIT, Survival, IHC, Patient, IVDR, ISO 13485, PCR, Union, CAP, Health, Death, Colorectal cancer, American Cancer Society, NASDAQ, Infection, CRC, U.S. Securities and Exchange Commission, Association, SEC, Cancer, Flow cytometry, Growth, Regulatory affairs, Quality, FDA, Medicine, DNA, Neoplasm, Compliance, Liquid biopsy, Company, ISO, Lead, IVD, Prospectus, Real-time polymerase chain reaction, Colon, Medical diagnosis, Security (finance), Food, Large intestine, Industry, News, Senior, Ageing, RT-PCR, Medical device, Pharmaceutical industry, Vaccine, US FDA, EU

Mainz BioMed Appoints Karen Richards as Vice President, Regulatory Affairs to Lead US FDA Approval Process

Key Points: 
  • Mainz BioMed Appoints Karen Richards as Vice President, Regulatory Affairs to Lead US FDA Approval Process
    The issuer is solely responsible for the content of this announcement.
  • BERKELEY, US - MAINZ, Germany - DECEMBER 21st, 2021 - Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the appointment of Karen Richards as its Vice President of Regulatory Affairs.
  • She has also been responsible for approval of laboratory tests in all U.S. states requiring a license, including New York State.
  • "I'm excited to join Mainz as it provides me with the opportunity to play an integral role in bringing to the U.S. market a unique test for this deadly form of cancer," commented Karen Richards, Vice President of Regulatory Affairs of Mainz BioMed.

Mainz BioMed Appoints Karen Richards as Vice President, Regulatory Affairs to Lead US FDA Approval Process

Retrieved on: 
Tuesday, December 21, 2021
Trial of the century, ISO 9001, COVID-19, CLIA, Biomarker, Private Securities Litigation Reform Act, Forward-looking statement, FIT, Survival, IHC, Patient, IVDR, ISO 13485, PCR, Union, CAP, Health, Death, Colorectal cancer, American Cancer Society, NASDAQ, Infection, CRC, U.S. Securities and Exchange Commission, Association, SEC, Cancer, Flow cytometry, Growth, Regulatory affairs, Quality, FDA, Medicine, DNA, Neoplasm, Compliance, Liquid biopsy, Company, ISO, IVD, Prospectus, GLOBE, Real-time polymerase chain reaction, Colon, Â, Medical diagnosis, Security (finance), Large intestine, Industry, Senior, Ageing, RT-PCR, Pharmaceutical industry, Vaccine, US FDA, EU

BERKELEY, Calif. and MAINZ, Germany, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (Mainz Biomed or the Company), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the appointment of Karen Richards as its Vice President of Regulatory Affairs.

Key Points: 
  • BERKELEY, Calif. and MAINZ, Germany, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (Mainz Biomed or the Company), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the appointment of Karen Richards as its Vice President of Regulatory Affairs.
  • She has also been responsible for approval of laboratory tests in all U.S. states requiring a license, including New York State.
  • Im excited to join Mainz as it provides me with the opportunity to play an integral role in bringing to the U.S. market a unique test for this deadly form of cancer, commented Karen Richards, Vice President of Regulatory Affairs of Mainz BioMed.
  • ColoAlert is currently marketed across Europe with FDA clinical study and submission process intended to be launched in the first half of 2022 for U.S. regulatory approval.

Renault Group and Dassault Systèmes strengthen their Partnership to Accelerate the Car Manufacturer's Transformation with the 3DEXPERIENCE Platform

Retrieved on: 
Tuesday, December 21, 2021
Software, Mobile, Wireless, Internet, Electronic Design Automation, Data Management, Alternative Vehicles, Fuels, General Automotive, Technology, Automotive, Automotive Manufacturing, Other Automotive, Other Technology, Manufacturing, 3D, Quality, Renault, Learning, Leadership, LADA, Alpine, DNA, SIMULIA, Technology, CEO, DELMIA, Product lifecycle, DNA Oyj, Transport, Mobilize, Software, CATIA, Solution, Partnership, Carbon, SOLIDWORKS, Industry, Dassault Group, Nissan, Multimedia, Dacia, Engineering, Mitsubishi Motors, Group, Connected, PLM, Motor vehicle, Video game console, Online shopping, GEOVIA, BIOVIA, Compass, ENOVIA

Renault Group will benefit from continuous technological evolutions and functional enrichment of the collaborative 3DEXPERIENCE platform on the cloud.

Key Points: 
  • Renault Group will benefit from continuous technological evolutions and functional enrichment of the collaborative 3DEXPERIENCE platform on the cloud.
  • We are fully engaged in this partnership and in supporting Renault Groups success, said Bernard Charls, Vice Chairman and CEO, Dassault Systmes.
  • As Renault Group moves to an enterprise platform, our partnership confirms that the 3DEXPERIENCE platform goes beyond vehicle creation and production.
  • Renault Group is relying on four Dassault Systmes industry solution experiences based on the 3DEXPERIENCE platform on the cloud: On-Target Vehicle Launch , Smart, Safe & Connected , Global Modular Architecture and Efficient Multi-Energy Platform .

Bioventus Receives US FDA Clearance for BoneScalpel® Access™

Retrieved on: 
Monday, December 20, 2021
Securities Act of 1933, Review, General surgery, Ovary, Senior, Forward-looking statement, LinkedIn, The Chartered Institute of Ergonomics and Human Factors, FDA, Projection, Physician, Growth, U.S. Securities and Exchange Commission, Sebaceous gland, Securities Exchange Act of 1934, Security (finance), Evidence-based medicine, Malignancy, Risk, GLOBE, Quality, Lipoma, Uterine fibroid, US Foods, Nasdaq, COVID-19, Gastrointestinal tract, Vestibular adenitis, SEC, Inclusion, Research, Neurosurgery, Terminology, Surgeon, Twitter, NEXUS, Failure, Food, Plastic and Reconstructive Surgery, Government, Company, Uterus, Cardiac fibroma, Orthopedic surgery, Patient, Sex, Cardiothoracic surgery, Innovation, Sebaceous cyst, Leiomyoma, Medical imaging, Dentistry, Gynaecology

DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, announced the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Companys neXus BoneScalpel Access handpiece.

Key Points: 
  • DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (Bioventus or the Company), a global leader in innovations for active healing, announced the US Food and Drug Administration (FDA) has granted 510(k) clearance for the Companys neXus BoneScalpel Access handpiece.
  • The BoneScalpel Access handpiece provides surgeons with a new option for confined spaces during minimally invasive surgery, enabling safe and powerful bone removal with maximum visualization.
  • Bioventus plans to launch BoneScalpel Access in 2022.
  • Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Searchlight Raises $17M Series A Round, Launches Talent Intelligence Platform to Help Companies Improve Quality of Hire With Behavioral Data and Prescriptive Analytics

Retrieved on: 
Monday, December 20, 2021
People, Organization, Workforce, Gaps, Self-assessment, General partnership, 1-Click, SAN, LinkedIn, Shasta Ventures, Science, Hire, High performance organization, Coda, Confluence, CEO, Work, Udemy, DNA, Mitch Kapor, Square, Efficiency, Quality, Plaid, Founders Fund, Cryptocurrency, Management, Employment agency, Accel, Talent

The company also announced the launch of its talent intelligence platform designed to align hiring teams to assess and retain great hires -- finally giving companies the ability to measure and improve quality of hire. Searchlight connects candidates' reference and self-assessment data to post-hire outcomes, creating a powerful hiring and retention engine that provides prescriptive insights. Using the platform, organizations can confidently hire faster, mitigate bias and retain a stronger workforce. Customers who have used the platform in beta to hire 1000s of candidates over the past year saw a 45% improvement in retention and 40% faster time-to-fill.

Key Points: 
  • Searchlight connects candidates' reference and self-assessment data to post-hire outcomes, creating a powerful hiring and retention engine that provides prescriptive insights.
  • Searchlight's platform connects behavioral data to employee outcomes so organizations have a holistic solution to measure and improve quality of hire.
  • Searchlight's prescriptive analytics recommends better practices and target candidate profiles to improve recruiting efficiency and quality of hire.
  • Searchlight is a talent intelligence platform that gives companies the ability to measure and improve quality of hire.